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Abstract
Objective—To analyze the effects of a decision aid on improving patients’ and family members’ 
information giving and question asking during consultations for prostate cancer treatment 
decision-making.
Methods—This study is a secondary analysis of archived audio-recorded real-time consultation 
visits with participants from a randomized clinical trial. Participants were randomly assigned into 
three groups: TD—intervention targeted patient-only; TS—intervention targeted patients and 
family members; and control—a handout on staying healthy during treatment. We conducted 
content analysis using a researcher-developed communication coding system. Using SAS 9.3, we 
conducted Chi-square/Fisher’s exact test to examine whether information giving and question 
asking among patients and family members varied by groups when discussing different content/
topics.
Results—Compared with those in the TS and control groups, significantly higher percentages of 
participants in the TD group demonstrated information giving in discussing topics about diagnosis, 
treatment options, risks and benefits, and preferences; and engaged in question asking when 
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discussing diagnosis, watchful waiting/active surveillance, risks and benefits, and preferences for 
treatment impacts.
Conclusion—Information support and communication skills training for patients were effective 
in improving communication during treatment decision-making consultations.
Practice implications—Providing information about prostate cancer and communication skills 
training empower patients and their family members.
Keywords
Localized prostate cancer; Decision-making; Patient-provider communication; Decision aid; 
Uncertainty; Intervention
1. Introduction
Prostate cancer is the most frequently diagnosed non-skin cancer for men in the U.S., with 
181,000 new cases diagnosed in 2016 [1]; approximately 90% have localized or regional 
disease Although several treatment options are available, no one is clearly superior in terms 
of mortality benefits and risks treatment complications and side-effects [3]. Given the about 
the optimal treatment strategy for localized cancer, the decision on whether and how to treat 
cancer is considered preference sensitive because and providers need to balance the 
significant impact treatment on patients’ quality and length of life [4]. Intentional 
cooperative communication between patients, their family and providers, thus, is critical in 
sharing knowledge, values, and preferences [5]. This communication can also help patients 
and their family members obtain balanced and comprehensive information; understand 
potential treatment options and their impacts; reflect on their values and preferences; and 
ultimately, enhance shared decision-making [6–8]. While patient-provider communication is 
critical during treatment decision-making, family members, especially their spouses, often 
attend consultation visits and are involved in discussing treatment options with both the 
patient and the providers [9,10] and directly assist in information giving and question asking 
during consultations [11]. Research has found that the presence of family members enhances 
patients’ communication behaviors such as asking questions [12,13] and active involvement 
in decision-making [13].
To help patients with localized prostate cancer make an informed treatment decision, 
intervention strategies in current decision aids include communication skills training or role 
modeling to improve communication between patients, their family members, and providers 
for clinical encounters [14–16]; providing information using multimedia [14,15,17–24]; 
facilitating value clarification and reducing decision conflicts [14,18,19,22,24]; and 
providing consultation plans and preparation materials [19,23–25]. Although improving 
communication skills for patients and their family members is one of the integral strategies 
in decision aid interventions for localized prostate cancer treatment choices, a recent 
systematic review and meta-analysis [5] found that patient-provider communication was 
evaluated only in one clinical trial using a Likert-type scale after consultation visits [16]. 
Patients’ and their family members’ communication behaviors during treatment decision-
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making consultation visits have not been evaluated as an outcome in decision aid research in 
the context of prostate cancer.
Research-to-date has analyzed real time recordings of medical encounters about physicians’ 
communication behaviors and the clinical visit structure within the context of treatment 
decision-making for prostate cancer [26,27] or used self-reported data collected from 
patients after treatment decisions were made [16,28–31]. Effective and competent physician-
directed communication constitutes only one of the core communication dimensions in 
cancer care [32]; patients and their family members also participate in the consultation and 
play a role in communication that is equally important to that of the providers. Patients’ 
responses to providers’ statements may significantly influence the content and structure of 
medical encounters as well as providers beliefs and behaviors [33]. Medical encounters such 
as treatment consultation visits are considered deliberation processes where patients and 
their family members become aware of choices and options, and have the time and support 
to consider what matters most to them; in other words a patient-centered approach to 
decision-making [7]. Therefore, it is important to examine patients’ and their family 
members’ communication behaviors (e.g., providing information, asking questions) when 
discussing specific topics related to treatment decision-making. Yet, commonly used patient 
self-reported retrospective data increase the risk for flawed recall [34] and social desirability 
bias [35]. Furthermore provider reported patient data do not reflect patient communication 
and participation in decision-making [30,36]. No decision aid studies to-date have assessed 
the real-time communication behaviors of patients with localized prostate cancer and their 
family members using audiotaped or videotaped data during treatment decision-making 
consultation visits.
To address these gaps, the purpose of this study was to analyze the effects of a decision aid 
on improving patients’ and their family members’ participation in communication focused 
on treatment decision-making for localized prostate cancer using real-time audio-recordings 
of consultation visits. Given the small proportion of family members actively involved in 
these consultations, we focused on the “joint” patient-family member communication with 
providers in each encounter (rather than the roles of individual participants in the 
consultations) and quantitatively examined the dynamic process information giving and 
question asking that occur during the verbal information exchange between providers, 
patients, and their family member(s) [6,37]. We hypothesized that higher percentages of 
patients and family members in the intervention groups would demonstrate more 
information giving and question asking behaviors than those in the control group.
2. Methods
2.1. Study design
This study is a secondary analysis of archived audio-recorded real-time consultation visits 
with participants from a randomized clinical trial (RCT) that tested the effects of a decision 
aid intervention in the southeast of USA [16]. Built upon the Uncertainty in Illness Theory 
[38], the Decision-Making Uncertainty Management Intervention (DMUMI) aimed to 
improve informed treatment decision-making for patients with localized prostate cancer by 
empowering patients and their family members through communication skills training and 
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information support [16]. In the RCT patients were randomly assigned to the treatment 
direct (TD, DMUMI targeted the patient-only), treatment supplemented (TS, DMUMI 
targeted the patient and his family member), or control (usual care plus a handout on staying 
healthy during treatment) groups [16].
The purpose of the consultation visits was for men and their family members to discuss 
treatment options and seek support for treatment decision-making after receiving their 
biopsy results and diagnosis. Physicians agreed to place a sign in their clinics announcing 
that consultation sessions would be randomly taped in order to verify the length of their 
interviews. Non-study patients that were newly diagnosed but refused to participate in the 
RCT or did not meet study criteria were approached and consented for the recording of 
random interviews; and their interview tapes were erased after their sessions. Consented 
physicians were blinded to the randomization and patient participation in the DMUMI by 
taping an equal number of non-study patients. Details describing the study sample and 
recruitment procedures were reported previously [16]. Approval was obtained from the 
Institutional Review Boards at all study sites.
2.2. Participants
In the RCT, patients were eligible if they (1) were newly diagnosed with localized prostate 
cancer (stages T1a, T1b, T1c, T2a or T2b); (2) were identified at least 10 days before the 
treatment consultation appointment; (3) had no major cognitive impairment; (4) had no prior 
cancer history; (5) could read and speak English; and (6) had a family member who was 
identified as providing primary support to the patient (PSP) and was willing to participate in 
the study. The study and recruitment process have been described previously [16]. All 
intervention and control groups contained both African-American and Caucasian men with 
prostate cancer. Among 410 men contacted, 343 were eligible, and 256 agreed to participate 
[16]. This study included 156 patients and their family members who provided demographic 
data and agreed to be recorded during their consultation visits (N = 54 in TD; N = 56 in TS; 
and N = 46 in Control).
2.3. The DMUMI intervention
As previously reported [16], patients in the TD and TS arms received a DVD, a booklet, and 
four phone calls. The only difference between the TD and TS groups was that patients’ PSPs 
in the TS group also received the same phone calls, separately, from the same nurse [16]. 
The professionally produced DVD, entitled “Talking to your doctor about prostate cancer,” 
was designed to demonstrate how to engage in effective communication using information 
giving, seeking, verifying, and clarifying skills. Actors portrayed Caucasian and African-
American men as prostate cancer patients in scenarios in which patients talked with their 
doctors about treatment options by providing information and asking questions. The booklet, 
“Treatment Choices for Early Stage Prostate Cancer: Patients’ Questions–Doctors’ 
Answers,” provided patient-focused, evidence-based guidelines to treatment issues for early 
stage prostate cancer. Participants could use the tear-out sheet in the back of the booklet to 
identify their personal concerns, specific questions about treatment options for their 
physicians, and record answers to their questions.
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Four nurse-delivered intervention calls over 7–10 days began immediately after participants 
received the DVD and booklet. These calls focused on participants’ questions about the 
content in the booklet and review of a handout on “The Competent Patient”. The nurses also 
helped participants to identify and formulate specific questions based on their concerns as 
well as review and practice using role-play the communication skills on the DVD and the 
strategies for using them.
2.4. Analytical approach
2.4.1. Patient characteristics measures—Patient characteristics information (i.e., age, 
education, and race) and prostate cancer information (i.e., Gleason score and prostate-
specific antigen, PSA) were collected using questionnaires prior to the randomization and 
treatment consultation visits.
2.4.2. Communication coding—To identify and analyze information giving and 
question asking behaviors when discussing prostate cancer treatment-related content/topics, 
we first used a communication coding system [39] developed previously by the research 
team based on the National Comprehensive Cancer Network (NCCN) treatment guideline 
for localized prostate cancer [40], theories on shared decision-making [7,41], and previous 
research on patient-provider communication [42,43] and medical consultation [37]. The 
measures included codes for communicators, communication behaviors, and content/topics 
of the consultation visits. The communicators included patients, their family members 
(including PSPs), and physician(s) at the consultations. The communication behaviors 
included information giving (any direct statement on a topic initiated by either a patient, a 
family member, or a physician about facts and evidence, personal thoughts and experiences) 
and question asking (any verbal attempt to seek, clarify, or verify information with a 
traditional interrogative form that included who, what, when, why, or how, or a subject-verb 
inversion (e.g., “Can I …”)). Information giving, clarifying, seeking, and verifying were the 
communication skills that DMUMI aimed to enhance. Communication content/topics 
included prostate cancer treatment-related topics in 4 domains: (a) delivering diagnosis 
(diagnosis, current prostate cancer-related symptoms, and patient health status/comorbid 
conditions related to decision-making); (b) treatment options of watchful waiting/active 
surveillance, surgery, and radiotherapy; (c) risks and benefits related to urinary and sexual 
side-effects, treatment procedures, complications, cancer progression and recurrence; and (d) 
patient/family member treatment preferences related to cancer control; treatment cost and 
health insurance coverage; patient life arrangement/employment; treatment impact on 
urinary and sexual functions; and more time to obtain additional input from others. These 
content/topics, critical for informed decision-making, have been promoted in the DMUMI. 
Use of different communication behaviors to cover these content/topics ensures that patients 
are supported to explore their preferences while being informed about treatment options and 
related risks, benefits, and impacts.
Using Atlas Ti 6© (Scientific Software Development GmbH, Berlin), five trained coders 
conducted a content analysis by independently coding whether the communication behaviors 
related to each content/topic category were present or absent in different communicators 
(i.e., coded as “Yes” and “No”, respectively). The communication behaviors of patients and 
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their family members were combined in each domain to capture the communication 
characteristics during the consultation visits. This decision was made due to the concerns 
that the study would not yield statistical results in most of the communication content/topics 
for family members. Family members of approximately 100 patients were not present at the 
consultation visits or did not engage in any verbal communication, resulting in extremely 
low sample sizes (such as zeros in all groups) in most of the communication content/topic 
areas in each study group. In addition, the communication behaviors among patients whose 
family members were not present at the consultations and those accompanied by family 
members with or without verbal communication may be different, which also resulted in 
sample sizes that were too small to generate any statistical results. In order to assess the 
effects of the DMUMI program, we thus decided to examine the communication 
characteristics of each encounter rather than to focus on individual participant’s roles and 
contributions in these consultations.
In addition, although more than one provider was involved during some consultation visits, 
consultations occurred separately with each provider. In order to capture all communication 
behaviors used by patients and their family members, we coded their communication 
behaviors as if they were interacting with one provider during one single interview. The 
decision to combine providers’ communication behaviors across interviews during the same 
consultation encounter was based on the consideration that patients and family members 
might use different communication behaviors when discussing the same content/topic (as 
listed above) with different providers to help understand their treatment options and make 
informed decisions.
The initial codebook was tested in the control group and later refined by all members of the 
coding team. A random sample of 25% of the transcripts (N = 40) was used to evaluate the 
inter-rater coding reliability. Each of these transcripts was independently coded by at least 
two coders; the percent agreement among coders was above 80%, indicating satisfactory 
inter-rater reliability [44,45]. During the study period, the research team had constant 
discussions weekly or biweekly about coding and related issues to reach consensus among 
coders.
2.5. Data analysis
Data analyses were conducted using SAS 9.3 (Cary, NC). Univariate analysis was conducted 
to describe the counts of communication behaviors within content/topic categories for 
patients and their family members. Chi-square test and Fisher’s exact test were used to 
examine whether patients’ and family members’ communication behaviors when discussing 
different contents varied by being in different groups (TD, TS, and control). We used two-
tailed tests and a p-value of 0.05 as a threshold to evaluate the null hypothesis.
3. Results
3.1. Participant characteristics
Table 1 presents the demographic information of patients and their PSPs. Thirty percent of 
patients and twenty-four percent of family members were African-Americans. On average, 
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patients were about 62 years of age and had 15 years of education; their family members 
were about 58 years of age and had 15 years of education. Close to 82% of the providers at 
the consultation visits were urologic surgeons; attending physicians presented at all visits 
whereas residents and fellows presented at 7.7% of the visits. Family members provided 
information at approximately 48%, 59%, and 49% of the visits in the TD, TS, and control 
groups, respectively. Significantly higher percentages of family members in the control 
group asked questions than those in the other two groups (p<0.01).
3.2. Patients’ and family members’ communication behaviors
1. Results of differences in information giving behaviors across groups are 
displayed in Fig. 1. Examples of quotes related to each communication content/
topic are in Table 2. The results showed a consistently higher percentage of 
patients and family members demonstrating information giving behaviors in the 
TD group than those in the TS and control groups when discussing topics across 
all communication content domains. Specifically, significantly higher 
percentages of patients and family members in the TD group than those in TS 
and control groups provided information about their prostate cancer diagnosis (p 
<0.001), prostate cancer-related current symptoms (p <0.01), and their health 
status and comorbid conditions (p <0.05). Compared with the TS and control 
groups, a significantly higher percentage of participants in the TD group 
provided their thoughts about watchful waiting/active surveillance (p <0.05). 
When discussing treatment-related risks and benefits, higher percentages of 
participants in the TD group than those in the TS and control groups provided 
information on topics about sexual (p <0.05) and urinary side-effects (p <0.01), 
treatment procedures (p <0.001), cancer progression (p <0.001), and treatment 
complications (p <0.01). Finally, among all communication topics about patient 
treatment preference, a significantly higher percentage of participants in the TD 
and control groups than those in the TS group provided information when 
discussing their preferences related to the impact of different types of treatment 
(p <0.01).
2. Results about question asking behaviors across groups are displayed in Fig. 2. 
Examples of quotes related to each communication content/topic are in Table 3. 
In the delivering diagnosis domain, a higher percentage of participants in the TD 
group engaged in question asking behaviors when discussing prostate cancer 
diagnosis (p <0.05) and patient’s health status and comorbid conditions (p <0.05) 
compared with those in the TS and control groups. Among all treatment options 
discussed, higher percentages of participants in the TD and TS groups than those 
in the control group asked questions related to watchful waiting/active 
surveillance. In the treatment risks and benefits domain, higher percentages of 
participants in the TD group asked questions about sexual side effects (p <0.01) 
and treatment complications (p<0.05), whereas a higher percentage of 
participants in the control group asked questions about treatment procedures (p 
<0.05). Finally, a higher percentage of participants in the TD group than those in 
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the other two groups asked questions about preferences related to treatment 
impacts (p <0.01).
4. Discussion and conclusion
4.1. Discussion
To our knowledge, this is the first study that has used direct observation (i.e., real-time audio 
recordings of consultation visits) to examine the effects of a decision aid on improving 
patients’ and their family members’ communication behaviors during consultation visits for 
prostate cancer treatment decision-making. Overall, our results indicated that higher 
percentages of patients and their family members in the TD group than those in the TS and 
control groups demonstrated information giving and question asking behaviors when 
discussing different content/topics related to treatment decision-making for prostate cancer. 
These results, partially confirmed our hypotheses, showed that the multi-component decision 
aid DMUMI targeting patient-only effectively enhanced patients’ and their family members’ 
information giving and questions asking behaviors when discussing different content/topics 
related to prostate cancer treatment decision-making during consultation visits. The DMUMI 
decision aid included a culturally sensitive DVD video demonstrating skills of information 
giving, seeking, verifying and clarifying for effective communication with providers; the 
information booklet about treatment options for early stage prostate cancer; and the nurses’ 
phone calls to educate and help patients practice communication skills [16]. These 
information and skills training not only informed patients about what to expect during 
prostate cancer treatment and consultation visits, but also empowered them to engage in 
interactions with physicians during consultation visits. Our findings among patients with 
newly diagnosed localized prostate cancer corroborated the findings of recent intervention 
research using video-clips among primary health-care patients [46] as well as the findings of 
a previous systematic review that reported patient-directed communication interventions 
(such as model communication behaviors, help practice question-asking skills) significantly 
increased question asking behaviors among patients with different illnesses [47].
It was somewhat surprising that lower percentages of participants in the TS group 
demonstrated information giving and question asking behaviors when discussing content/
topics related to diagnosis, treatment procedures, and preferences of treatment impacts than 
those in the TD group. It is likely that prior to their consultation visits, patients and their 
family members, when both were involved in the DMUMI, received more information from 
the multi-component intervention about prostate cancer that was pertinent to the patient’s 
condition. They may also have discussed the related issues with the intervention nurse and 
between themselves, especially the psychosocial issues related to prostate cancer. These 
information and discussions ahead of the consultation visit, in turn, may have resulted in a 
reduction in their subsequent requests for additional information from physicians than what 
had been provided during consultation. A recent meta-analysis found that family presence 
helped patient information giving and question asking during medical visits. However, 
physicians engaged in more biomedical information giving and less social conversation, and 
patients provided less psychosocial information [11]. Prostate cancer and its treatment can 
impact both patients’ physical and psychosocial well-being; patients depend on their family, 
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especially their partners, for social and emotional support. Compared with the intervention 
targetting patient-only (TD), involving both patients and family members in the intervention 
(TS) may have equipped them with skills needed to discuss more freely private and sensitive 
issues related to prostate cancer and its treatment, and thus, reduced their needs for more 
information exchange with their providers at consultation visits.
It was interesting that, compared with those in the TD and TS groups, a significantly higher 
percentage of patients and family members in the control group asked questions about 
treatment procedures and physician recommendations for treatment. In the original RCT, 
patients in the control group received information about how to stay healthy during 
treatment for prostate cancer, which may have increased patients’ and family members’ 
concerns about the treatment procedures and thus may have led them to ask more related 
questions for physicians to clarify. Lacking sufficient information about prostate cancer and 
its treatments (such as options, risks and benefits) and communication skills training may 
also have led these patients and their family members to ask for providers’ 
recommendations.
Finally, our findings indicated that, compared with those in the TD group, significantly 
higher percentages of family members in the TS and control groups asked questions during 
the consultation visits, despite the fact that patients and family members in the TS and 
control groups engaged in singnificantly less information giving and question asking than 
those in the TD group. In a recent study using KINcode to analyze communication behaviors 
in cancer consultations, researchers found that family members interrupted or answered for 
the patients; prompted patient questions; summarized or repeated information for the patient; 
and made optimistic/positive statements [48]. Our future research needs to examine whether 
the patients and their family members in the DMUMI study engaged in similar patterns of 
communication, which may have contributed to our findings.
The limitations of this study warrant further research. This study examined the effects of the 
overall DMUMI on information giving and question asking behaviors during consultations 
for prostate cancer treatment. Future research is needed to determine the effects of different 
intervention components (e.g., the DVD, nurse phone calls, and the booklet) and different 
dosages of the intervention (e.g., 4 versus fewer nurse calls) so as to provide clinicians the 
evidence to enhance oncologic care that requires the least resources. Next, we focused on 
verbal communication but did not examine the nonverbal behaviors or the affective 
component although they are all critical aspects of communication. Additionally, we 
analyzed the audio recordings of one consultation visit of each patient although patients with 
prostate cancer may have had more than one clinical visit or contact that was not face-to-
face and may have discussions with others and/or used other decision support [7]. In 
addition, the data available from the RCT only allowed us to quantitatively examine the 
effects of DMUMI on the “joint” communication behaviors of patients and family members 
because a limited number of family members presented at the consultations and/or actively 
participated in the communication. Future research, however, is needed to explore the roles 
and contributions of the individual participants in these encounters. Research is also needed 
to examine the family dynamics; their impact on the communication among patients, family 
members, and providers; and the benefits, challenges, and strategies to facilitate family 
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involvement to enhance healthcare outcomes. Finally, this study focused on the 
communication behaviors of patients and family members, which may have simplified the 
interpersonal process in which providers played an extremely important role in eliciting 
patient and family concerns [49]. Future research is needed to explore the complexity of the 
communication interactions during treatment consultation visits.
4.2. Conclusion
The DMUMI program that provided information support and communication skills training 
to patients with newly diagnosed localized prostate cancer was effective in improving 
information giving and question asking behaviors in patients and their family members when 
they jointly discussed about cancer diagnosis, treatment options, risks and benefits, and 
treatment preferences during treatment decision-making consultation visits. The same 
decision aid intervention targeting both patients and their family members may decrease 
their needs for extensive information exchange during consultations.
4.3. Practice implications
In addition to providing treatment-related information for localized prostate cancer, it is 
important to provide communication skills training to patients and their family members to 
empower their interaction with healthcare providers.
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Fig. 1. 
Comparison of patient and family companion information giving behaviors among groups.
Note: TD—intervention targeted patient-only; TS—intervention targeted patients and family 
members; C—Control group.
Song et al. Page 14
Patient Educ Couns. Author manuscript; available in PMC 2018 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 2. 
Comparison of patient and family companion question asking behaviors among groups.
Note: TD—intervention targeted patient-only; TS—intervention targeted patients and family 
members; C—Control group.
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Table 2
Patient and family information giving communication behaviors during consultation visits.
Domains Contents/Topics Example of Quotes
Delivering diagnosis Current symptoms related to prostate 
cancer
• Well that wasn’t being an issue cause I have Peyronie’s, you 
know, and I’ve. And that’s certainly increased the erection 
dysfunction (Patient).
• He got where he was having problems emptying his bladder 
and he went to the doctor at the emergency room (Family 
Member).
Diagnosis • All I know is I’ve had an enlarged prostate …For five or six 
years I’ve had an enlarged prostate. Until now they hadn’t 
found anything that they, warned of the cancer. But I 
continued to have and have had for four or five years, 
urination issues (Patient).
• It was a lymph node cancer scare. You know, I had all the 
symptoms. Every symptom. The doctor told me that the only 
way that they could tell that it was to do biopsy (Patient).
Patient’s health status/comorbid 
condition(s)
• I have hepatitis C (Patient).
• He’s, for his age, you know, he’s extremely fit and healthy 
because compared to my brother, he’s in better shape than my 
brother is (laughter) because he exercises all the time (Wife).
Treatment options Watchful waiting/active surveillance na
Radiation therapy • We done some reading, and on the surface it seems that the, 
the complication factor was more or less involved in terms of 
the radiation, either beam or the brachitherapy. And, rather 
than the surgery (Patient).
• …I’d almost made up my mind to have the uh, brachystherapy 
(Patient).
Surgery • I still think I prefer the surgery if it’s, if I’m qualified to go for 
it (Patient).
Risks and benefits Urinary side effects • Well, that (urinary urgency) would really interfere with my 
job. Say, if I’m in a meeting with the city manager, and I’ve 
gotta go, gotta go (Patient).
• The incontinence is a pain in the ass if you have to wear a pad 
all the time, and leaking and things of this nature, and I’m 
fully aware of the fact that chance exists (with radiation 
therapy) (Patient).
Sexual side effects • I really don’t want to take that Viagra stuff (after surgery) 
unless I don’t have no problems (Patient).
Treatment procedure • I ’m glad you said that, because it’s a seven and a half week, 
and I read something about once you started the strong beam 
radiation, there was a six-months course of treatment, and I 
thought (Patient).
• I was thinking about with the seed implants, you’re under 
anesthesia, and I was wondering what the risks were of that 
(Patient).
Treatment Complications • I’m not worried about the pain (during and after surgery) after 
having gone through the shoulder surgery. The pain doesn’t 
bother me (Patient).
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Domains Contents/Topics Example of Quotes
• I know one of the books I have says you can have a pain about 
a week later. It would be like the pain would stay there the 
whole time (Patient).
Cancer progression and recurrence • We’re still in a stage now that it’s a grade I, highly treatable 
with anything whether it’s we go for the robotic surgery, 
whether we go for the radical surgery, whether we go for the 
seeds, whether, every, the whole field is open right now. If it, 
if this thing becomes aggressive, which it could become 
aggressive overnight, we don’t know (Patient).
Treatment preference Cancer control/cancer free result • My primary focus is the cancer-free part of it. I plan on living 
at least another 20 years.
• I want to get rid of the cancer and don’t worry about it 
(Patient).
• He has a real hard time dealing with things and, you know, he 
has said from day one “I want to get this out. I want to have 
surgery. I want to know it’s out.” (Family member)
Treatment cost and insurance coverage • It (waiting for a few months before surgery) would be 
beneficial also from the financial standpoint because of my 
insurance (Patient).
• My insurance requires a pre-approval (for my treatment of 
prostate cancer) (Patient).
Provider recommendation • I tend to favor brachytherapy with debating radiation, 
listening to your opinion (Patient).
• He (the doctor who diagnosed my cancer) would prefer the 
seeds (Patient).
Patient life arrangement/employment • I could possibly get the publisher to postpone if I were to have 
surgery immediately, but if I were to wait a half-year or so, 
hope to have the book done (Patient).
• I am not working right now but I am a bricklayer (Patient).
Treatment impact • Since I know the guy, (he has been) very active, and another 
thing that I’m concerned about is this thing (radiation related 
fatigue) going to slow him way down because he does not like 
to be slowed down (Wife).
• The continence doesn’t bother me, so we will just move on 
(Patient).
• I’m knowledgeable enough about the general thing that I, you 
know, to go to surgery and end up incontinent, you know, to 
me would be just a way to die. You know, I have no interest in 
taking any significant risk just to stay alive (Patient).
More time to obtain input from others • I have a colleague, Dr. H who is a distinguished pathologist 
and we’re going to request that all of his slides going back to 
‘96 be sent to him so that he can just look at everything …It’s 
just another eye. And he may modify the Gleason grade a 
little bit either one way or the other, so it’s just another facet 
of this that we want to explore (Patient).
• Monday, no, as soon as possible. Monday’s good. February 
16. No sense in giving that thing a chance to grow more than 
it already has (Patient).
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Table 3
Patient and family question asking communication behaviors during consultation visits.
Domains Contents/Topics Example of Quotes
Delivering diagnosis Current symptoms related to prostate 
cancer Diagnosis
• Is that anything affecting this (urinary problems) or is it a 
large prostate? (Family member)
• Is there a Stage number? When you say both sides, does that 
mean it is a T2? How many biopsies are done? (Patient)
• What is the, what’s that T1C stand for again? (Family 
Member)
• What is the term where it grows outside the prostate gland, 
the test— whatever? (Patient)
Patient’s health status/comorbid 
condition(s)
• With my previous Crohn’s problems, taking out my colon and 
all, would that keep me from having the radiation treatments? 
(Patient)
Treatment options Watchful waiting/active surveillance • Would you, from your experience, tell me a little about what 
goes on if a person elected observation? How frequently he 
will be seen and by whom? (Patient)
• What is your thought on that (watchful waiting/active 
surveillance) with my situation? (Patient)
Radiation therapy • What are the seeds made out of? What is the vehicle that 
carries the radioactive material? What happens to the seeds? 
Do they just stay there? (Patient)
• What about the similarity of side effects with the seeds? What 
is the frequency of the side effects during the course of the 
radiation itself? (Patient)
Surgery • How about the nerves? Do they have to be surgically cut or 
scraped off of the prostate? Are they lifted off? (Patient)
Risks and benefits Sexual side effects • What kind of pill (for erections)? And the reason is? Why 
would that (giving patient Cialis after surgery) have a long-
term effect? (Patient)
• What about erectile dysfunction percentage wise from each 
one of these (surgery and radiation therapy)? (Patient)
Urinary side effects • While the seeds are in, do you have incontinence? (Patient)
• How long is that (burning and slow urination after 
treatment)? (Patient)
• What are the medicines that we can, you know, we can try for 
that (urinary problems)? (Family Member)
Treatment procedure • With beam, if we decided to do that, we would begin when? 
Would you elaborate, too, on the personnel who help to make 
this measurement for the radiation in order that the right 
dosage is given? (Patient)
Treatment Complications • Could one expect to be fatigued for a year (after radiation 
therapy)? What are the chances of my dying from the 
treatment? (Patient)
• How about blood loss (related to surgery)? (Family member)
• How long will the pain usually last after the seeds? (Patient)
Cancer progression and recurrence • What are the chances of my cancer spreading causing 
symptoms within 10 years?
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Domains Contents/Topics Example of Quotes
• How is the recurrence with surgical removal? (Patient)
Treatment preference Cancer control/cancer free result • By cure do you mean – – I read about five percent, ten 
percent relative cure rate, right? (Patient)
• If I decided to go with seeds or whatever, what the percentage 
of curing the thing I guess, or not curing it, whatever? 
(Patient)
Treatment cost and insurance coverage • Is there any financial issues I should (be thinking of)? I’ve 
got Aetna. And I assume that I’ve got pretty – is there any 
financial issues I need to concern …is there one that’s much 
more costly than the other? (Patient)
• You guys take care of all that (pre-approval), right? Or do I 
have to call? (Patient)
Physician recommendation • For someone his age and with the level that he has, what 
would you recommend? What treatment are you doing now 
for people, in his, say his age and weight? (Family member)
• Which do you recommend? You don’t recommend doing 
nothing now? (Patient)
• Which ones you recommend and which ones you would feel 
comfortable if it were your son or brother or dad or whoever, 
you know, which direction would you go with the stage of the 
cancer that I’m at today? (Patient)
Patient life arrangement/employment • My wife, who is my caregiver, has a meeting she’d like to go 
to. She leaves on the tenth and comes back on the fourteenth. 
Now, how long a hospital stay will I have? (Patient)
• How long would you expect to stay out of work? (Patient)
Treatment impact • If I took the seed implants, would that curtail my activities a 
whole lot? (Patient)
• What about driving around in a truck (do I leak)? My job is I 
fix copy machines and I get in a straight-drive truck, a little 
Ford Ranger, and go from one job to the other (Patient).
More time to obtain input from others • Is there an immediately need to go into the surgery or can I 
take X months or years before I have the surgery to remove 
the whole thing? (Patient)
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